Clustering of alpha-synuclein on supported lipid bilayers: role of anionic lipid, protein, and divalent ion concentration.
暂无分享,去创建一个
Jean-Christophe Rochet | Farzin Haque | J. Rochet | Anjan P Pandey | Farzin Haque | J. Hovis | Jennifer S Hovis
[1] Hitoshi Takahashi,et al. NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease , 1997, Neuroscience Letters.
[2] V. Buchman,et al. Part II: α-synuclein and its molecular pathophysiological role in neurodegenerative disease , 2003, Neuropharmacology.
[3] V. Uversky,et al. Conformational behavior and aggregation of alpha-synuclein in organic solvents: modeling the effects of membranes. , 2003, Biochemistry.
[4] L. Forno,et al. Neuropathology of Parkinson's Disease , 1996, Journal of neuropathology and experimental neurology.
[5] V. Uversky,et al. Conformational properties of the SDS-bound state of alpha-synuclein probed by limited proteolysis: unexpected rigidity of the acidic C-terminal tail. , 2006, Biochemistry.
[6] H. Vorum,et al. Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization. , 2001, The Journal of biological chemistry.
[7] Seung-Jae Lee,et al. Membrane-bound α-Synuclein Has a High Aggregation Propensity and the Ability to Seed the Aggregation of the Cytosolic Form* , 2002, The Journal of Biological Chemistry.
[8] Ralf Langen,et al. Structure of membrane-bound α-synuclein studied by site-directed spin labeling , 2004 .
[9] Reinhard Jahn,et al. A Broken α-Helix in Folded α-Synuclein* , 2003, The Journal of Biological Chemistry.
[10] H. Kato,et al. Calcium-triggered membrane interaction of the alpha-synuclein acidic tail. , 2006, Biochemistry.
[11] S. Pasquaré,et al. Age-Associated Changes in Central Nervous System Glycerolipid Composition and Metabolism , 2002, Neurochemical Research.
[12] D. Lynch,et al. Functional consequences of alpha-synuclein tyrosine nitration: diminished binding to lipid vesicles and increased fibril formation. , 2004, The Journal of biological chemistry.
[13] A. Verkhratsky,et al. Parameters of calcium homeostasis in normal neuronal ageing , 2000, Journal of anatomy.
[14] P. Barton,et al. Phase behavior of synthetic phosphatidylglycerols and binary mixtures with phosphatidylcholines in the presence and absence of calcium ions. , 1978, Biochemistry.
[15] S E Ide,et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.
[16] K. Beyer. Mechanistic aspects of Parkinson's disease: alpha-synuclein and the biomembrane. , 2007, Cell biochemistry and biophysics.
[17] M. Citron,et al. Both Familial Parkinson’s Disease Mutations Accelerate α-Synuclein Aggregation* , 1999, The Journal of Biological Chemistry.
[18] J Q Trojanowski,et al. Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies. , 1998, The American journal of pathology.
[19] S. Scarlata,et al. Membrane binding and self-association of alpha-synucleins. , 2001, Biochemistry.
[20] J. Trojanowski,et al. Synucleins Are Developmentally Expressed, and α-Synuclein Regulates the Size of the Presynaptic Vesicular Pool in Primary Hippocampal Neurons , 2000, The Journal of Neuroscience.
[21] L. Serpell,et al. Mutation E46K increases phospholipid binding and assembly into filaments of human alpha-synuclein. , 2004, FEBS letters.
[22] T. Lazaridis,et al. Membrane‐bound structure and energetics of α‐synuclein , 2008 .
[23] Janel O. Johnson,et al. α-Synuclein Locus Triplication Causes Parkinson's Disease , 2003, Science.
[24] D. Harries,et al. Lipid demixing and protein-protein interactions in the adsorption of charged proteins on mixed membranes. , 2000, Biophysical journal.
[25] D. Leckband,et al. Structure and dynamics of ion-induced domains in free and supported monolayers and bilayers , 1994 .
[26] P. S. St George-Hyslop,et al. α-Synuclein Membrane Interactions and Lipid Specificity* , 2000, The Journal of Biological Chemistry.
[27] P. Axelsen,et al. The E46K mutation in alpha-synuclein increases amyloid fibril formation. , 2005, The Journal of biological chemistry.
[28] D. Eliezer,et al. A structural and functional role for 11-mer repeats in alpha-synuclein and other exchangeable lipid binding proteins. , 2003, Journal of molecular biology.
[29] J Q Trojanowski,et al. A Hydrophobic Stretch of 12 Amino Acid Residues in the Middle of α-Synuclein Is Essential for Filament Assembly* , 2001, The Journal of Biological Chemistry.
[30] P. Lansbury,et al. Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[31] Farzin Haque,et al. Effect of surface treatment on diffusion and domain formation in supported lipid bilayers. , 2007, Biophysical journal.
[32] A. Hinderliter,et al. Domain formation in a fluid mixed lipid bilayer modulated through binding of the C2 protein motif. , 2001, Biochemistry.
[33] M. L. Schmidt,et al. α-Synuclein in Lewy bodies , 1997, Nature.
[34] Jean-Christophe Rochet,et al. Helical alpha-synuclein forms highly conductive ion channels. , 2007, Biochemistry.
[35] A. Jonas,et al. Stabilization of α-Synuclein Secondary Structure upon Binding to Synthetic Membranes* , 1998, The Journal of Biological Chemistry.
[36] J. Kordower,et al. Age-associated increases of α-synuclein in monkeys and humans are associated with nigrostriatal dopamine depletion: Is this the target for Parkinson's disease? , 2007, Neurobiology of Disease.
[37] M. Mattson,et al. Calcium and neurodegeneration , 2007, Aging cell.
[38] Olaf Riess,et al. AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.
[39] T. Dawson,et al. Molecular Pathways of Neurodegeneration in Parkinson's Disease , 2003, Science.
[40] H. Budka,et al. Nigral burden of α‐synuclein correlates with striatal dopamine deficit , 2008, Movement disorders : official journal of the Movement Disorder Society.
[41] A. Doig,et al. A study of the regional effects of alpha-synuclein on the organization and stability of phospholipid bilayers. , 2006, Biochemistry.
[42] R. Krüger,et al. Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease. , 1998, Nature genetics.
[43] Min Zhu,et al. Lipid binding inhibits alpha-synuclein fibril formation. , 2003, The Journal of biological chemistry.
[44] P. Lansbury,et al. The impact of the E46K mutation on the properties of alpha-synuclein in its monomeric and oligomeric states. , 2007, Biochemistry.
[45] R. Crowther,et al. α-Synuclein in filamentous inclusions of Lewy bodies from Parkinson’s disease and dementia with Lewy bodies , 1998 .
[46] E. Wanker,et al. Alpha-synuclein selectively binds to anionic phospholipids embedded in liquid-disordered domains. , 2008, Journal of molecular biology.
[47] S. May,et al. Domain formation induced by the adsorption of charged proteins on mixed lipid membranes. , 2005, Biophysical journal.
[48] A. Blume,et al. The mixing behavior of pseudobinary phosphatidylcholine-phosphatidylglycerol mixtures as a function of pH and chain length , 1997, European Biophysics Journal.
[49] P. Riekkinen,et al. Interaction between dopamine and phospholipids. Studies of the substantia nigra in Parkinson disease patients. , 1975, Archives of neurology.
[50] J. Hovis,et al. Influence of lipid chemistry on membrane fluidity: tail and headgroup interactions. , 2006, Biophysical journal.
[51] D. Marsh,et al. Alpha-synuclein association with phosphatidylglycerol probed by lipid spin labels. , 2003, Biochemistry.
[52] D. Dickson,et al. Pathology and Biology of the Lewy Body , 1993, Journal of neuropathology and experimental neurology.
[53] Richard Paylor,et al. Synaptic Vesicle Depletion Correlates with Attenuated Synaptic Responses to Prolonged Repetitive Stimulation in Mice Lacking α-Synuclein , 2002, The Journal of Neuroscience.
[54] A. Sidhu,et al. α‐Synuclein regulation of the dopaminergic transporter: a possible role in the pathogenesis of Parkinson's disease , 2004 .
[55] E. Sackmann,et al. Supported Membranes: Scientific and Practical Applications , 1996, Science.
[56] J. Hoenicka,et al. The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia , 2004, Annals of neurology.
[57] Jeff Kuret,et al. Rapid anionic micelle-mediated alpha-synuclein fibrillization in vitro. , 2003, The Journal of biological chemistry.
[58] D. Price,et al. Stabilization of α-Synuclein Protein with Aging and Familial Parkinson's Disease-Linked A53T Mutation , 2004, The Journal of Neuroscience.
[59] D. Eliezer,et al. Helix periodicity, topology, and dynamics of membrane-associated alpha-synuclein. , 2005, Protein science : a publication of the Protein Society.
[60] V. Uversky,et al. Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. , 2001, Biochemistry.
[61] P. Lansbury,et al. NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded. , 1996, Biochemistry.
[62] K. Wakabayashi,et al. The cellular pathology of Parkinson's disease , 2001, Neuropathology (Kyoto. 1993).